Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

BACKGROUND: Nowadays, researchers are leveraging the mRNA-based vaccine technology used to develop personalized immunotherapy for cancer. However, its application against glioma is still in its infancy. In this study, the applicable candidates were excavated for mRNA vaccine treatment in the perspec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hua, Liu, Shuai, Cao, Fang, Zhao, Yi, Zhou, Jianguo, Tang, Feng, Peng, Zhaohua, Li, Yangsheng, Xu, Shen, Wang, Chunlin, Yang, Guohua, Li, Zhi-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429949/
https://www.ncbi.nlm.nih.gov/pubmed/34512630
http://dx.doi.org/10.3389/fimmu.2021.709986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429949/
https://www.ncbi.nlm.nih.gov/pubmed/34512630
http://dx.doi.org/10.3389/fimmu.2021.709986

Ejemplares similares